Previous close | 0.1000 |
Open | 0.1000 |
Bid | 0.0000 |
Ask | 1.5000 |
Strike | 440.00 |
Expiry date | 2023-10-20 |
Day's range | 0.1000 - 0.1000 |
Contract range | N/A |
Volume | |
Open interest | 10 |
GE Healthcare's potential windfall from Leqembi approval is being hampered by CMS coverage of PET scans.
With its stock down 14% over the past three months, it is easy to disregard Biogen (NASDAQ:BIIB). But if you pay close...
In the latest trading session, Biogen Inc. (BIIB) closed at $258.44, marking a -0.19% move from the previous day.